Pages that link to "Q36633205"
Jump to navigation
Jump to search
The following pages link to Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? (Q36633205):
Displaying 24 items.
- Serum Sclerostin Levels in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis (Q33695718) (← links)
- Update on ankylosing spondylitis: current concepts in pathogenesis (Q34450732) (← links)
- Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study (Q34457833) (← links)
- Frontiers in the bioarchaeology of stress and disease: cross-disciplinary perspectives from pathophysiology, human biology, and epidemiology (Q35216868) (← links)
- Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis (Q35809286) (← links)
- To Wnt or not to Wnt: the bone and joint health dilemma (Q36794846) (← links)
- Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis (Q38198090) (← links)
- Wnt signaling in ankylosing spondylitis (Q38211262) (← links)
- Seronegative arthritis in Latin America: a current review (Q38229478) (← links)
- Vitamin D and spondyloarthritis (Q38262855) (← links)
- The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward (Q38569186) (← links)
- The ongoing quest for biomarkers in Ankylosing Spondylitis (Q38607774) (← links)
- Urolithiasis as an extraarticular manifestation of ankylosing spondylitis (Q38640178) (← links)
- Chronic Periodontitis Is Associated With Spinal Dysmobility in Patients With Ankylosing Spondylitis (Q40624375) (← links)
- Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis. (Q41067642) (← links)
- Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis (Q46379699) (← links)
- Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway (Q47755895) (← links)
- Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus. (Q48895837) (← links)
- Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study. (Q55008112) (← links)
- Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis (Q90111774) (← links)
- Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs (Q91645594) (← links)
- Biomarker development for axial spondyloarthritis (Q96817691) (← links)
- An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision (Q97421408) (← links)
- lncRNA MEG3 Suppresses the Progression of Ankylosis Spondylitis by Regulating the Let-7i/SOST Axis (Q98466734) (← links)